Gene · 4301
Papers1,720
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,720
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of Placentation and the Role of the Aryl Hydrocarbon Receptor Pathway in a Rat Model of Dioxin Exposure. | Environ Health Perspect | 2021 | 34747641 | PubTator, text mining | PubMed |
| The Impact of Environmental Pollutants on Barrier Dysfunction in Respiratory Disease. | Allergy Asthma Immunol Res | 2021 | 34734504 | PubTator, text mining | PubMed |
| Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report. | Braz J Med Biol Res | 2021 | 34730684 | PubTator, text mining | PubMed |
| Circulating miR-185-5p as a Potential Biomarker for Arrhythmogenic Right Ventricular Cardiomyopathy. | Cells | 2021 | 34685557 | PubTator, text mining | PubMed |
| Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans. | Biomedicines | 2021 | 34680588 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblast Functions as a Road-Block in Cancer Therapy. | Cancers (Basel) | 2021 | 34680395 | PubTator, text mining | PubMed |
| Automated CUT&Tag profiling of chromatin heterogeneity in mixed-lineage leukemia. | Nat Genet | 2021 | 34663924 | PubTator, text mining | PubMed |
| [Clinical characteristics and prognosis of MLL-AF6 positive patients with acute myeloid leukemia]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2021 | 34650294 | PubTator, text mining | PubMed |
| Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancer. | Biol Direct | 2021 | 34641953 | PubTator, text mining | PubMed |
| ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape. | Int J Mol Sci | 2021 | 34639154 | PubTator, text mining | PubMed |
| Impact of KMT2A Rearrangement and CSPG4 Expression in Pediatric Acute Myeloid Leukemia. | Cancers (Basel) | 2021 | 34638301 | PubTator, text mining | PubMed |
| Steroid Receptors in Breast Cancer: Understanding of Molecular Function as a Basis for Effective Therapy Development. | Cancers (Basel) | 2021 | 34638264 | PubTator, text mining | PubMed |
| KMT2A-CBL rearrangements in acute leukemias: clinical characteristics and genetic breakpoints. | Blood Adv | 2021 | 34638131 | PubTator, text mining | PubMed |
| Role of Barrier Integrity and Dysfunctions in Maintaining the Healthy Gut and Their Health Outcomes. | Front Physiol | 2021 | 34630140 | PubTator, text mining | PubMed |
| Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia. | Cancer Cell Int | 2021 | 34627254 | PubTator, text mining | PubMed |
| Pathogenicity and virulence of Listeria monocytogenes: A trip from environmental to medical microbiology. | Virulence | 2021 | 34612177 | PubTator, text mining | PubMed |
| Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders. | Open Biol | 2021 | 34610269 | PubTator, text mining | PubMed |
| Drug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)-Gene Rearrangements. | Front Pharmacol | 2021 | 34594227 | PubTator, text mining | PubMed |
| Effects of Environmental and Pathological Hypoxia on Male Fertility. | Front Cell Dev Biol | 2021 | 34589489 | PubTator, text mining | PubMed |
| Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements. | Blood Cancer J | 2021 | 34588432 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4301/papers?page=20